367 related articles for article (PubMed ID: 27602793)
1. Immune responses to polyclonal T-cell vaccination in patients with progressive multiple sclerosis.
Seledtsova GV; Ivanova IP; Shishkov AA; Seledtsov VI
J Immunotoxicol; 2016 Nov; 13(6):879-884. PubMed ID: 27602793
[TBL] [Abstract][Full Text] [Related]
2. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
[TBL] [Abstract][Full Text] [Related]
3. T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study.
Van der Aa A; Hellings N; Medaer R; Gelin G; Palmers Y; Raus J; Stinissen P
Clin Exp Immunol; 2003 Jan; 131(1):155-68. PubMed ID: 12519400
[TBL] [Abstract][Full Text] [Related]
4. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
5. T cell vaccination in secondary progressive multiple sclerosis.
Correale J; Lund B; McMillan M; Ko DY; McCarthy K; Weiner LP
J Neuroimmunol; 2000 Jul; 107(2):130-9. PubMed ID: 10854647
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M
Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474
[TBL] [Abstract][Full Text] [Related]
7. Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination.
Kyte JA; Trachsel S; Risberg B; thor Straten P; Lislerud K; Gaudernack G
Cancer Immunol Immunother; 2009 Oct; 58(10):1609-26. PubMed ID: 19221745
[TBL] [Abstract][Full Text] [Related]
8. Vaccines for multiple sclerosis: progress to date.
Correale J; Farez M; Gilmore W
CNS Drugs; 2008; 22(3):175-98. PubMed ID: 18278975
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis.
Vandenbark AA; Culbertson NE; Bartholomew RM; Huan J; Agotsch M; LaTocha D; Yadav V; Mass M; Whitham R; Lovera J; Milano J; Theofan G; Chou YK; Offner H; Bourdette DN
Immunology; 2008 Jan; 123(1):66-78. PubMed ID: 17944900
[TBL] [Abstract][Full Text] [Related]
11. Anti-idiotypic regulatory responses induced by vaccination with DNA encoding murine TCR Valpha5 and Vbeta2.
Wu Y; Zhang Y; Xu X; Lv P; Gao X
Cell Mol Immunol; 2007 Aug; 4(4):287-93. PubMed ID: 17764619
[TBL] [Abstract][Full Text] [Related]
12. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M
Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590
[TBL] [Abstract][Full Text] [Related]
13. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults.
Boer MC; Prins C; van Meijgaarden KE; van Dissel JT; Ottenhoff TH; Joosten SA
Clin Vaccine Immunol; 2015 Jul; 22(7):778-88. PubMed ID: 25947145
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy.
Coscia M; Mariani S; Battaglio S; Di Bello C; Fiore F; Foglietta M; Pileri A; Boccadoro M; Massaia M
Leukemia; 2004 Jan; 18(1):139-45. PubMed ID: 14574332
[TBL] [Abstract][Full Text] [Related]
17. The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review.
Huang X; Wu H; Lu Q
Clin Rev Allergy Immunol; 2014 Oct; 47(2):219-33. PubMed ID: 25096807
[TBL] [Abstract][Full Text] [Related]
18. Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen.
Neelapu SS; Baskar S; Gause BL; Kobrin CB; Watson TM; Frye AR; Pennington R; Harvey L; Jaffe ES; Robb RJ; Popescu MC; Kwak LW
Clin Cancer Res; 2004 Dec; 10(24):8309-17. PubMed ID: 15623607
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of autologous tumor vaccination, anti-CD3-activated vaccine-primed lymphocytes, and interleukin-2 in stage IV renal cell cancer.
Chang AE; Li Q; Jiang G; Sayre DM; Braun TM; Redman BG
J Clin Oncol; 2003 Mar; 21(5):884-90. PubMed ID: 12610189
[TBL] [Abstract][Full Text] [Related]
20. Increased CD8+ central memory T cells in patients with multiple sclerosis.
Liu GZ; Fang LB; Hjelmström P; Gao XG
Mult Scler; 2007 Mar; 13(2):149-55. PubMed ID: 17439879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
